scienc
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
background
pandem
caus
coronaviru
threaten
global
public
health
current
neutral
antibodi
nab
versu
viru
expect
correl
recoveri
protect
diseas
howev
characterist
antibodi
well
studi
associ
clinic
manifest
patient
plasma
collect
recov
patient
mild
symptom
screen
use
safe
sensit
pseudotypedlentiviralvectorbas
neutral
assay
spikebind
antibodi
plasma
determin
elisa
use
rbd
protein
level
time
cours
specif
nab
spikebind
antibodi
monitor
time
variat
specif
nab
recov
patient
may
rais
concern
role
nab
diseas
progress
correl
nab
titer
age
lymphocyt
count
blood
crp
level
suggest
interplay
viru
host
immun
respons
coronaviru
infect
explor
develop
effect
vaccin
viru
furthermor
titrat
nab
help
prior
use
convalesc
plasma
prevent
treatment
outbreak
coronaviru
diseas
decemb
spread
around
world
becom
global
pandem
etiolog
agent
identifi
sarsrel
coronaviru
design
coronaviru
march
caus
total
case
infect
result
death
worldwid
infect
patient
show
mild
symptom
sever
symptom
dyspnea
high
respiratori
frequenc
low
blood
oxygen
satur
anoth
patient
especi
comorbid
progress
critic
condit
use
pseudotypedlentiviralvectorbas
neutral
assay
measur
nab
plasma
recov
patient
mild
symptom
pseudoviru
psv
neutral
assay
sensit
reproduc
assay
produc
highli
pathogen
viru
safe
handl
biosafeti
level
facil
herein
aim
explor
clinic
characterist
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
elisa
rbd
protein
sarscov
rbd
protein
coat
maxisorp
nuncimmuno
plate
overnight
well
block
nonfat
milk
pb
hour
room
temperatur
follow
median
length
hospit
stay
day
rang
day
median
diseas
durat
day
day
collect
five
plasma
sampl
patient
time
discharg
measur
neutral
titer
infect
cell
five
plasma
show
concentrationdepend
inhibit
psv
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
infect
cell
figur
plasma
high
titer
nab
show
higher
titer
rbd
bind
antibodi
figur
moreov
plasma
patient
also
show
crossbind
srascov
rbd
region
figur
bind
sarscov
protein
consist
observ
nab
titer
variabl
plasma
recov
patient
rang
detect
limit
figur
recov
patient
gener
low
level
nab
titer
figur
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
supplementari
tabl
nab
titer
ten
limit
detect
though
lab
confirm
infect
supplementari
tabl
show
mediumlow
mediumhigh
high
nab
titer
respect
figur
also
collect
measur
level
nab
plasma
patient
followup
examin
two
week
discharg
shown
figur
observ
elderli
patient
like
induc
higher
titer
nab
younger
patient
shown
figur
patient
divid
three
group
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
left
right
howev
none
patient
progress
sever
condit
signific
differ
observ
age
length
hospit
stay
among
patient
figur
interestingli
observ
nab
titer
neg
correl
blood
lymphocyt
count
r
p
figur
left
posit
correl
blood
crp
level
r
p
figur
also
noteworthi
level
nab
patient
variabl
patient
fail
develop
high
titer
nab
infect
howev
diseas
durat
patient
compar
other
similar
notabl
ten
recov
patient
whose
nab
titer
low
detect
level
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
nab
titer
patient
also
observ
correl
age
patient
elderli
patient
significantli
higher
titer
nab
younger
patient
antibodi
therapi
easi
task
perform
use
psv
neutral
assay
correl
nab
titer
age
lymphocyt
count
blood
crp
level
patient
also
lay
groundwork
studi
explor
mechan
nab
develop
patient
declar
compet
interest
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
acknowledg
want
particularli
acknowledg
dr
lu
review
manuscript
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
brown
six
patient
plasma
shown
compar
kinet
nab
titer
right
axi
red
patient
c
correl
nab
titer
rbd
bind
antibodi
level
patient
analyz
pearson
correl
test
dilut
plasma
incub
rbd
protein
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
